A PYMNTS Company

EU: Mylan to Teva: ‘Stop meddling in our affairs’

By  |  June 2, 2015

Mylan Executive Chairman Robert Coury is telling Teva Pharmaceutical Industries to “stop playing games with our company” in a strongly worded letter released Monday.

    Get the Full Story

    Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional logins required.

    yesSubscribe to our daily newsletter, PYMNTS Today.

    By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions.

    Teva said back in April it wanted to make a $40 billion bid to acquire the generic pharmaceutical company that is run out of Washington County. The bid was rejected by Mylan’s board — and Coury in a strongly worded responses — but Teva has kept interest even as Mylan pursues its own unsolicited bid for another generic pharmaceutical company, Perrigo plc.

    Coury wrote that without “an actual offer” or the timing, Teva should provide “unequivocal clarification” about what it wants to do with Mylan. The letter was sent to Teva’s CEO and also filed with the SEC.

    Full content: Bloomberg

    Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.